SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-20-026203
Filing Date
2020-02-27
Accepted
2020-02-27 16:31:48
Documents
80
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K espr-20191231x10k209bec.htm   iXBRL 10-K 2199822
2 GRAPHIC espr-20191231x10k209bec001.jpg GRAPHIC 31073
3 EX-4.4 ex-4d4.htm EX-4.4 29607
4 EX-10.16 ex-10d16.htm EX-10.16 3405
5 EX-23.1 ex-23d1.htm EX-23.1 11317
6 EX-31.1 ex-31d1.htm EX-31.1 11700
7 EX-31.2 ex-31d2.htm EX-31.2 12279
8 EX-32.1 ex-32d1.htm EX-32.1 9098
  Complete submission text file 0001104659-20-026203.txt   8592378

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE espr-20191231.xsd EX-101.SCH 59490
10 XBRL CALCULATION FILE espr-20191231_cal.xml EX-101.CAL 65622
11 XBRL DEFINITION FILE espr-20191231_def.xml EX-101.DEF 194669
12 XBRL LABEL FILE espr-20191231_lab.xml EX-101.LAB 565982
13 XBRL PRESENTATION FILE espr-20191231_pre.xml EX-101.PRE 390616
74 EXTRACTED XBRL INSTANCE DOCUMENT espr-20191231x10k209bec_htm.xml XML 1537666
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35986 | Film No.: 20662669
SIC: 2834 Pharmaceutical Preparations